Keylika alternatives
TL;DR: 12 companies doing similar work to Keylika in Healthcare, ranked by how closely they match what Keylika actually does — not just by category.
How this list was built: every company here is Y Combinator-backed and shares at least one category with Keylika. They are scored on how closely their own description overlaps with Keylika's, and all facts shown come from the YC company records — nothing is estimated.
What are the best alternatives to Keylika?
| Alternative | What it does | Batch | Team | Status |
|---|---|---|---|---|
| Mind Emulation Foundation | — | Winter 2018 | 1 | Active |
| Excepgen | — | Winter 2019 | 3 | Active |
| ResistanceBio | We solve drug resistance for cancer | Winter 2019 | 15 | Inactive |
| Atlas Discovery | AI-native pharma company | Summer 2026 | 3 | Active |
| Velorum Therapeutics | Breakthrough medicines unlocking the biology of heme | Winter 2024 | 5 | Active |
| Gerostate Alpha | Developing novel therapeutics for aging and chronic disease | Summer 2018 | 6 | Inactive |
| Nuntius Therapeutics | Cell-specific genetic medicines | Winter 2021 | 2 | Active |
| Watsi | Watsi is the first global crowdfunding platform for medical… | Winter 2013 | 11 | Active |
| Entelexo Biotherapeutics | Creating a New Class of Drugs to Address Incurable Autoimmune Diseases | Winter 2021 | 3 | Active |
| Dorian Therapeutics | New therapeutics to rejuvenate tissue and treat age-related diseases | Summer 2018 | 8 | Acquired |
| Serna Bio | Genetic Medicine with Small Molecules | Winter 2021 | 5 | Active |
| Intact Therapeutics | Smart gels for local drug delivery to the gut | Winter 2019 | 4 | Active |
Is Keylika still active?
Keylika is still operating, so switching is a choice rather than a forced migration. Compare on fit and price rather than urgency.
How was this list put together?
Every company here is Y Combinator-backed and shares at least one category with Keylika. They are then ranked on how closely their own description overlaps with Keylika's, so the closest matches come first rather than whoever happens to share a tag.